ليتروزول تيڤع

מדינה: ישראל

שפה: ערבית

מקור: Ministry of Health

מרכיב פעיל:

LETROZOLE 2.5 MG

זמין מ:

TEVA PHARMACEUTICAL INDUST.LTD

קוד ATC:

L02BG04

טופס פרצבטיות:

TABLETS

מסלול נתינה (של תרופות):

PER OS

תוצרת:

TEVA PHARMACEUTICAL INDUSTRIES LTD

קבוצה תרפויטית:

LETROZOLE

סממני תרפויטית:

Letrozole teva tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole teva is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

תאריך אישור:

2010-01-01